Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers
Checkpoint blockade therapy is effective against many cancers; however, new targets need to be identified to treat patients who do not respond to current treatment or demonstrate immune escape. Here, we showed that blocking the inhibitory receptor Killer cell lectin-like receptor G1 (KLRG1) enhances...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2021-01-01
|
| Serie: | OncoImmunology |
| Soggetti: | |
| Accesso online: | http://dx.doi.org/10.1080/2162402X.2021.1933808 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|